Preferred Label : Ultomiris;
Origin ID : M000646389;
Related record
- See also inter- (CISMeF)
https://www.has-sante.fr/jcms/p_3281239/fr/ultomiris-300-mg/3-ml-ravulizumab
2021
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
Ultomiris
ravulizumab
infusions, intravenous
complement inactivating agents
ravulizumab
paroxysmal nocturnal hemoglobinuria
adult
Atypical Hemolytic Uremic Syndrome
---
https://www.has-sante.fr/jcms/p_3274202/fr/ultomiris-ravulizumab-shua
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Product containing only ravulizumab in parenteral dose form (medicinal product form)
Atypical Hemolytic Uremic Syndrome
complement inactivating agents
ravulizumab
adult
child
evaluation of the transparency committee
ravulizumab
Ultomiris
antibodies, monoclonal, humanized
---
